2017 | 2018 | 2019 | 2020 | 2021 | |||||||||||
TD (N = 199) | Malaria RDT (N = 1852) | COVID RDT (N = 0) | TD (N = 214) | Malaria RDT (N = 2138) | COVID RDT (N = 0) | TD (N = 201) | Malaria RDT (N = 3742) | COVID RDT (N = 0) | TD (N = 158) | Malaria RDT (N = 2097) | COVID RDT (N = 8) | TD (N = 147) | Malaria RDT (N = 1036) | COVID RDT (N = 444) | |
<5 years | 28 (14.7%; CI 95 = 5.1 - 24.3) | 270 (14.6%; CI 95 = 13.1 - 16.3) | 0 | 18 (8.4%; CI 95 = 4.7 - 12.1) | 287 (13.4%; CI 95 = 12 - 14.8) | 0 | 31 (15.4%; CI 95 = 10.5 - 20.3) | 775 (20.7%; CI 95 = 19.5 - 21.9) | 0 | 145 (91.7%; CI 95 = 87.4 - 96) | 1549 (73.8%; CI 95 = 72 - 75.6) | 0 | 15 (10.2%; CI 95 = 5.4 - 15) | 338 (32.6%; CI 95 = 29.8 - 35.4) | 16 (3.6%; CI 95 = 1.9 - 5.3) |
>5 years | 169 (84.9%; CI 95 = 80 - 89.8) | 1582 (85.4%; CI 95 = 83.8 - 87) | 0 | 189 (88.3%; CI 95 = 84 - 92.6) | 1851 (86.6%; CI 95 = 85.2 - 88) | 0 | 169 (84.1%; CI 95 = 79.1 - 89.1) | 2967 (79.3%; CI 95 = 78.1 - 80.5) | 0 | 9 (5.6%; CI 95 = 2.1 - 9.1) | 548 (26.2%; CI 95 = 24.4 - 28) | 0 | 122 (83%; CI 95 = 77 - 89) | 698 (67.4%; CI 95 = 64.6 - 70.2) | 407 (91.6%; CI 95 = 89.1 - 94.1) |
ND* | 2 (0.4%; CI 95 = 0 - 1.2) | 0 | 0 | 7 (3.3%; CI 95 = 1 - 5.6) | 0 | 0 | 1 (0.5%; CI 95 = 0 - 1.4) | 0 | 0 | 4 (2.7%; CI 95 = 0.2 - 5.2) | 0 | 8 (100%) | 10 (6.8%; CI 95 = 2.8 - 10.8) | 0 | 21 (4.8%; CI 95 = 2.9 - 6.7) |